IP Library Assignment 035279/0701
Patent Assignment
Reel/Frame 035279/0701

Change of Name

Recorded: 2015-03-27 Pages: 3
Assignor
ALKERMES SCIENCE ONE LIMITED
Executed: 2014-08-12
Assignee
DARAVITA LIMITED
CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, IRELAND
Covered Properties (9)
Reduction of Intravenously Administered Nanoparticulate-Formulation- Induced Adverse Physiological Reactions
Patent: 5,834,025 →
Application: 08/696,754 →
Compositions Having a Combination of Immediate Release and Controlled Release Characteristics
Patent: 6,908,626 →
Application: 10/268,928 →
Publication: US 2003/0137067
Nanoparticulate Compositions Having Lysozyme as a Surface Stabilizer
Patent: 7,459,283 →
Application: 10/357,514 →
Publication: US 2003/0185869
Nanoparticulate meloxicam formulations
Patent: 8,512,727 →
Application: 10/784,900 →
Publication: US 2004/0229038
Reduction of Intravenously Administered Nanoparticulate-Formulation-Induced Adverse Physiological Reactions
Patent: 41,884 →
Application: 12/027,100 →
Nanoparticulate Compositions Having Lysozyme as a Surface Stabilizer
Patent: 8,323,641 →
Application: 12/292,091 →
Publication: US 2009/0074875
Method of Treatment Using Nanoparticulate Compositions Having Lysozyme as a Surface Stabilizer
Patent: 8,652,464 →
Application: 13/693,858 →
Publication: US 2013/0224123
Nanoparticulate Meloxicam Formulations
Application: 13/941,076 →
Publication: US 2014/0141083
Method of Treatment Using Nanoparticulate Compositions Having Lysozyme as a Surface Stabilizer
Application: 14/182,097 →
Publication: US 2014/0234225
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Patent Security Agreement (Second Lien) Sep 29, 2011
From: ALKERMES, INC.; ALKERMES PHARMA IRELAND LIMITED; ALKERMES CONTROLLED THERAPEUTICS INC.
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 026994/0245 →
Patent Security Agreement (First Lien) Sep 29, 2011
From: ALKERMES, INC.; ALKERMES PHARMA IRELAND LIMITED; ALKERMES CONTROLLED THERAPEUTICS INC.
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 026994/0186 →
Change of Name Oct 2, 2012
From: EDT PHARMA HOLDINGS LIMITED
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 029064/0645 →
Asset Transfer Agreement Oct 2, 2012
From: ELAN PHARMA INTERNATIONAL LIMITED
To: EDT PHARMA HOLDINGS LIMITED
Reel/Frame 029066/0655 →
Asset Transfer Agreement Oct 10, 2012
From: ELAN PHARMA INTERNATIONAL LIMITED
To: EDT PHARMA HOLDINGS LIMITED
Reel/Frame 029108/0426 →
Change of Name Oct 10, 2012
From: EDT PHARMA HOLDINGS LIMITED
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 029104/0071 →
Change of Name Oct 10, 2012
From: EDT PHARMA HOLDINGS LIMITED
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 029103/0695 →
Assignment of Assignor's Interest Oct 10, 2012
From: ELAN PHARMA INTERNATIONAL LIMITED
To: EDT PHARMA HOLDINGS LIMITED
Reel/Frame 029103/0465 →
Release by Secured Party (Second Lien) Oct 12, 2012
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: ALKERMES, INC.; ALKERMES PHARMA IRELAND LIMITED; ALKERMES CONTROLLED THERAPEUTICS INC.
Reel/Frame 029116/0379 →
Asset Transfer Agreement Apr 12, 2014
From: ELAN PHARMA INTERNATIONAL LIMITED
To: EDT PHARMA HOLDINGS LIMITED
Reel/Frame 032672/0001 →
Change of Name Apr 12, 2014
From: EDT PHARMA HOLDINGS LIMITED
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 032661/0663 →
Property Transfer Agreement Aug 6, 2014
From: ALKERMES PHARMA IRELAND LIMITED
To: ALKERMES SCIENCE ONE LIMITED
Reel/Frame 033483/0891 →
Property Transfer Agreement Aug 12, 2014
From: ALKERMES PHARMA IRELAND LIMITED
To: ALKERMES SCIENCE ONE LIMITED
Reel/Frame 033522/0048 →
Transfer Agreement Mar 26, 2015
From: ALKERMES PHARMA IRELAND LIMITED
To: ALKERMES SCIENCE ONE LIMITED
Reel/Frame 035295/0945 →
Asset Transfer and License Agreement Apr 10, 2015
From: ALKERMES PHARMA IRELAND LIMITED
To: DV TECHNOLOGY LLC
Reel/Frame 035410/0001 →
Business Transfer Agreement Apr 10, 2015
From: DARAVITA LIMITED
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 035409/0831 →
Security Interest Apr 14, 2015
From: RECRO TECHNOLOGY LLC
To: ORBIMED ROYALTY OPPORTUNITIES II, LP
Reel/Frame 035403/0288 →
Change of Name Apr 16, 2015
From: DV TECHNOLOGY LLC
To: RECRO TECHNOLOGY LLC
Reel/Frame 035446/0904 →
Release of Security Interest Apr 27, 2015
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: DARAVITA LIMITED (F/K/A ALKERMES SCIENCE ONE LIMITED, SUCCESSOR IN INTEREST TO ALKERMES PHARMA IRELAND LIMITED)
Reel/Frame 035505/0696 →
Merger Aug 31, 2016
From: RECRO TECHNOLOGY LLC
To: RECRO GAINESVILLE LLC
Reel/Frame 039602/0035 →
Assignment of Assignor's Interest Sep 14, 2016
From: COOPER, EUGENE R.; RYDE, TUULA; PRUITT, JOHN; KLINE, LAURA
To: ELAN PHARMA INTERNATIONAL LTD.
Reel/Frame 039735/0791 →
Change of Name Sep 22, 2016
From: EDT PHARMA HOLDINGS LIMITED
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 040107/0640 →
Asset Transfer Agreement Sep 22, 2016
From: ELAN PHARMA INTERNATIONAL LIMITED
To: EDT PHARMA HOLDINGS LIMITED
Reel/Frame 040107/0521 →
Merger Sep 23, 2016
From: RECRO TECHNOLOGY LLC
To: RECRO GAINESVILLE LLC
Reel/Frame 039841/0365 →
Assignment of Assignor's Interest Oct 5, 2016
From: RECRO GAINESVILLE LLC
To: RECRO IRELAND LIMITED
Reel/Frame 039946/0789 →